Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
BRGXBioregenx, Inc.
| Figure | BRGXBioregenx, Inc.FY2025 · Dec |
|---|---|
| Revenue | $1.85M |
| Revenue, yoy | −20.8% |
| Net income | $1.54M |
| Net income, yoy | +93.3% |
| Net margin | -83.2% |
| Free cash flow | $29.92K |
| FCF margin | 1.6% |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed